Clinical Trial Update: Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on combining capecitabine with docetaxel for advanced or recurrent cervical cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of California, Irvine | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED